Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Collegium Pharma (NQ: COLL )

23.99 -0.38 (-1.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 353,807
Open 24.55
Bid (Size) 21.50 (20)
Ask (Size) 30.10 (5)
Prev. Close 24.37
Today's Range 23.95 - 25.00
52wk Range 14.04 - 30.22
Shares Outstanding 34,066,568
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
From Collegium Pharmaceutical, Inc.
Via Globe NewsWire
Earnings Outlook For Collegium Pharmaceutical
 
Via Benzinga

Performance

YTD
+1.74%
+1.74%
1 Month
-10.45%
-10.45%
3 Month
+3.41%
+3.41%
6 Month
+49.75%
+49.75%
1 Year
+17.83%
+17.83%

More News

Read More
Collegium Publishes Inaugural 2022 Environmental, Social and Governance Report
From Collegium Pharmaceutical, Inc.
Via Globe NewsWire
Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
From Collegium Pharmaceutical, Inc.
Via Globe NewsWire
Analyst Sees This 'Specialty Pharma' Stock Stuck Until Prescription Trends Improve
Via Benzinga
Recap: Collegium Pharmaceutical Q1 Earnings
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering
From Collegium Pharmaceutical, Inc.
Via Globe NewsWire
Why Collegium Pharmaceutical's Shares Are Trading Higher Today
Via Benzinga
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
From Collegium Pharmaceutical, Inc.
Via Globe NewsWire
Collegium Provides 2023 Financial Guidance
From Collegium Pharmaceutical, Inc.
Via Globe NewsWire
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
From Collegium Pharmaceutical, Inc.
Via Globe NewsWire
Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via Globe NewsWire
Collegium Reports Third Quarter 2022 Financial Results
From Collegium Pharmaceutical, Inc.
Via Globe NewsWire
Collegium to Report Third Quarter 2022 Financial Results on November 3, 2022
From Collegium Pharmaceutical, Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
Via Benzinga
7 Micro-Cap Stocks to Take a Chance on Now
Via InvestorPlace
A Preview Of Collegium Pharmaceutical's Earnings
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Analyst Ratings For Collegium Pharmaceutical
Via Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.